A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro

Published:2012-07-23 Issue:7 Volume:7 Page:e41235
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chang Chien-Hsing,Hinkula Jorma,Loo Meiyu,Falkeborn Tina,Li Rongxiu,Cardillo Thomas M.,Rossi Edmund A.,Goldenberg David M.,Wahren Britta

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic.;S Broder;Antiviral Res,2010

2. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.;M Coiras;Nat Rev Microbiol,2009

3. The challenge of finding a cure for HIV infection.;DD Richman;Science,2009

4. The fusion inhibitor enfuvirtide in recent antiretroviral strategies.;A Makinson;Curr Opin HIV AIDS,2009

5. Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes.;T Matthews;Nat Rev Drug Discov,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Conjugates for Targeted Therapy Against HIV-1 as an Emerging Tool for HIV-1 Cure;Frontiers in Immunology;2021-07-01

2. A 30 kDa polyethylene glycol-enfuvirtide complex enhances the exposure of enfuvirtide in lymphatic viral reservoirs in rats;European Journal of Pharmaceutics and Biopharmaceutics;2019-04

3. A novel peptide shows excellent anti-HIV-1 potency as a gp41 fusion inhibitor;Bioorganic & Medicinal Chemistry Letters;2018-03

4. In situ depot formation of anti-HIV fusion-inhibitor peptide in recombinant protein polymer hydrogel;Acta Biomaterialia;2017-12

5. Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses;Human Vaccines & Immunotherapeutics;2017-07-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3